LNAI
Lunai Bioworks Inc.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | → $0.26 | -61% |
| Millennium Management | Q4 2025 | Q2 2026 | → $0.26 | -76% |
| Two Sigma Investments | Q4 2025 | Q1 2026 | → $0.67 | -37% |
| Renaissance Technologies | Q4 2025 | Q1 2026 | → $0.82 | -21% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Lunai Bioworks Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Mar 12, 2025 — the most recent Form 4 on file — not from today.
- Form 40001214659-25-004233Mar 12, 2025
- Form 40001731122-25-000295Feb 25, 2025
- Form 40001731122-25-000293Feb 25, 2025
- Form 40001731122-24-001740Nov 7, 2024
- Form 40001731122-24-001729Nov 6, 2024
- Form 40001731122-24-001725Nov 6, 2024
- Form 40001731122-24-001719Nov 6, 2024
- Form 40001731122-24-001669Oct 29, 2024
- Form 40001214659-24-017879Oct 24, 2024
- Form 40001731122-24-001325Aug 27, 2024
- Form 4/Aamend0001213900-24-070297Aug 16, 2024
- Form 40001213900-24-068233Aug 13, 2024
- Form 40001214659-24-012745Jul 19, 2024
- Form 4/Aamend0001214659-24-012744Jul 19, 2024
- Form 4/Aamend0001214659-24-012743Jul 19, 2024
Fundamentals
XBRL · Lunai Bioworks Inc.Annual figures sourced directly from Lunai Bioworks Inc.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Lunai Bioworks Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KMay 20, 2026
- 10-QFORM 10-QMay 15, 2026
- 8-KFORM 8-KMay 13, 2026
- 8-K/AFORM 8-K/AMay 11, 2026
- 8-KFORM 8-KMay 1, 2026
- 8-KFORM 8-KApr 28, 2026
- DEF 14AFORM DEF 14AApr 13, 2026
- 8-KFORM 8-KMar 30, 2026
- 8-KFORM 8-KMar 5, 2026
- 8-KFORM 8-KFeb 23, 2026
- 10-QFORM 10-QFeb 17, 2026
- 8-KFORM 8-KFeb 12, 2026
- 8-KFORM 8-KDec 3, 2025
- 8-KFORM 8-KNov 25, 2025
- 10-QFORM 10-QNov 14, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Citadel Advisors | Q1 2026 | Q2 2026 | $0.67 | $0.26 | -61% |
| Two Sigma Investments | Q4 2025 | Q1 2026 | $1.06 | $0.67 | -37% |
| Millennium Management | Q4 2025 | Q2 2026 | $1.06 | $0.26 | -76% |
| Renaissance Technologies | Q4 2025 | Q1 2026 | $1.03 | $0.82 | -21% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.